Dr Chibuzo Udoka Enemchukwu, | |
707 E Main St, Middletown, NY 10940-2650 | |
(845) 333-7575 | |
(845) 333-7201 |
Full Name | Dr Chibuzo Udoka Enemchukwu |
---|---|
Gender | Female |
Speciality | Internal Medicine - Infectious Disease |
Location | 707 E Main St, Middletown, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144529900 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 036154364 (Illinois) | Secondary |
207RI0200X | Internal Medicine - Infectious Disease | 286303 (New York) | Primary |
Entity Name | Montefiore Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
We all are aware that washing our hands can help us in preventing the spread of germs and getting ill. According to a new study by Rutgers-New Brunswick published in the June issue of the Journal of Food Protection, cool water removes the same amount of harmful bacteria as that of hot water.
Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer's disease.
Socioeconomic factors predominantly explain racial and ethnic disparities in prostate cancer outcomes, according to a new study.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
› Verified 6 days ago
Entity Name | St Josephs Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942501747 PECOS PAC ID: 4688855844 Enrollment ID: O20110221000744 |
News Archive
We all are aware that washing our hands can help us in preventing the spread of germs and getting ill. According to a new study by Rutgers-New Brunswick published in the June issue of the Journal of Food Protection, cool water removes the same amount of harmful bacteria as that of hot water.
Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer's disease.
Socioeconomic factors predominantly explain racial and ethnic disparities in prostate cancer outcomes, according to a new study.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
› Verified 6 days ago
Entity Name | Metropolitan Medical Practice Plan Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306138383 PECOS PAC ID: 8022286384 Enrollment ID: O20110713000171 |
News Archive
We all are aware that washing our hands can help us in preventing the spread of germs and getting ill. According to a new study by Rutgers-New Brunswick published in the June issue of the Journal of Food Protection, cool water removes the same amount of harmful bacteria as that of hot water.
Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer's disease.
Socioeconomic factors predominantly explain racial and ethnic disparities in prostate cancer outcomes, according to a new study.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Chibuzo Udoka Enemchukwu, 707 E Main St, Middletown, NY 10940-2650 Ph: (845) 333-7575 | Dr Chibuzo Udoka Enemchukwu, 707 E Main St, Middletown, NY 10940-2650 Ph: (845) 333-7575 |
News Archive
We all are aware that washing our hands can help us in preventing the spread of germs and getting ill. According to a new study by Rutgers-New Brunswick published in the June issue of the Journal of Food Protection, cool water removes the same amount of harmful bacteria as that of hot water.
Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer's disease.
Socioeconomic factors predominantly explain racial and ethnic disparities in prostate cancer outcomes, according to a new study.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the completion of its initial public offering of 9,000,000 shares of its common stock. All shares were sold at an initial public offering price of $9.00 per share, resulting in aggregate net proceeds to AVEO of approximately $72,580,000 after deducting underwriting discounts and commissions and estimated offering expenses.
› Verified 6 days ago
Dr. Aamir Masood Gilani, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575 Fax: 845-333-7202 | |
Dr. Dahlia Banerji, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774 | |
Rafeel O Syed, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Nancy I. Linneman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Dr. Corina Cristescu, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774 Fax: 845-818-7555 | |
Dr. Robert Lewis Douglas, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 210 E Main St, Middletown, NY 10940 Phone: 845-342-5681 Fax: 845-342-0470 | |
Peggy Nelson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 |